These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 23180531)

  • 21. Identifying and Overcoming Clopidogrel Resistance: Where Do We Stand?
    Galli M; Pereira N
    J Cardiovasc Pharmacol; 2024 Sep; 84(3):316-318. PubMed ID: 38922573
    [No Abstract]   [Full Text] [Related]  

  • 22. PON1 Q192R and clopidogrel: a case of the winner's curse or inadequate replication?
    Talameh JA; McLeod HL
    Clin Pharmacol Ther; 2011 Dec; 90(6):771-4. PubMed ID: 22089342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiaggregants in the treatment of patients with ischemic heart disease].
    Sidorenko BA; Botolova EN; Golikova AA
    Kardiologiia; 1993; 33(3):78-84. PubMed ID: 8377347
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelet function testing in patients with coronary artery disease: is the Who and the When any clearer than the What and the What then?
    Rade JJ
    Circulation; 2012 Jun; 125(25):3073-5. PubMed ID: 22619281
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study.
    Fontana P; James R; Barazer I; Berdagué P; Schved JF; Rebsamen M; Vuilleumier N; Reny JL
    J Thromb Haemost; 2011 Aug; 9(8):1664-6. PubMed ID: 21692977
    [No Abstract]   [Full Text] [Related]  

  • 26. Factors that contribute to clopidogrel resistance in cardiovascular disease patients: environmental and genetic approach.
    Al-Azzam SI; Alzoubi KH; Khabour OF; Nusair MB; Al-Hadidi H; Awidi A; Saleh A
    Int J Clin Pharmacol Ther; 2013 Mar; 51(3):179-86. PubMed ID: 23357840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Besides CYP2C19, PON1 genetic variant influences post-clopidogrel platelet reactivity in Chinese patients.
    Wu H; Qian J; Xu J; Sun A; Sun W; Wang Q; Ge J
    Int J Cardiol; 2013 Apr; 165(1):204-6. PubMed ID: 22974728
    [No Abstract]   [Full Text] [Related]  

  • 28. [Genetic factors influencing efficacy of clopidogrel treatment].
    Karaźniewicz-Łada M; Danielak D; Główka F
    Kardiol Pol; 2012; 70(11):1177-81. PubMed ID: 23180531
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic determinants of on-clopidogrel high platelet reactivity.
    Campo G; Miccoli M; Tebaldi M; Marchesini J; Fileti L; Monti M; Valgimigli M; Ferrari R
    Platelets; 2011; 22(6):399-407. PubMed ID: 21627411
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.